PCN93 - Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer

Journal article

Open access

Peer reviewed

V Diaby, G Adunlin, A Ali, S Zeichner, G Lopes, C G Kohn and A J Montero

Value in health, Vol.19(3), pp.A150-A150

2016-05

Files and links (1)

url

https://doi.org/10.1016/j.jval.2016.03.1592View

Published (Version of record) Open

1 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: PCN93 - Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer
Creators: V Diaby - Florida Agricultural and Mechanical University
G Adunlin - Virginia Commonwealth University
A Ali - Florida Agricultural and Mechanical University
S Zeichner - Emory University
G Lopes - Hospital do Coração
C G Kohn - Hartford Hospital
A J Montero - Cleveland Clinic
Publication Details: Value in health, Vol.19(3), pp.A150-A150
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713801702976